Enterolactone suppresses proliferation, migration and metastasis of MDA-MB-231 breast cancer cells through inhibition of uPA induced plasmin activation and MMPs-Mediated ECM remodeling

Asian Pacific Journal of Cancer Prevention

Volumn 18, Issue 4, 2017, Pages 905-915

  Mali, Aniket V ^a,b   Joshi, Asavari A ^a   Hegde, Mahabaleshwar V ^a   Kadam, Shivajirao S ^b  

^a Bharati Vidyapeeth   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Breast cancer; Enterolactone; Matrix metalloproteinases; Urokinase type plasminogen activator

Indexed keywords

EID: 85019614557     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.22034/APJCP.2017.18.4.905     Document Type: Article

References (55)

1. Alphonse P, Aluko R (2015). A review on the anti-carcinogenic and anti-metastatic effects of flax seed lignan secolariciresinol diglucoside (SDG). Discov Phytomedicine, 2, 12-7.
2. Andreasen PA, Egelund R, Petersen HH (2000). The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci, 57, 25-40.
3. Bissell MJ, Radisky D (2001). Putting tumours in context. Nat Rev Cancer, 1, 46-54.
4. Butcher DT, Alliston T, Weaver VM (2009). A tense situation: forcing tumour progression. Nat Rev Cancer, 9, 108-22.
5. Carriero MV, Stoppelli MP (2011). The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling. Curr Pharm De, 17, 1944-61.
6. Chaudhary AK, Chaudhary S, Ghosh K, et al (2016). Pleiotropic roles of metalloproteinases in hematological malignancies: an update. Asian Pacific J Cancer Prev, 17, 3043-51.
7. Chen J, Power KA, Mann J, et al (2007). Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med, 232, 1071-80.
8. Chen J, Stavro PM, Thompson LU (2002). Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer, 43, 187-92.
9. Chen J, Thompson LU (2003). Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat, 80, 163-70.
10. Chen J, Wang L, Thompson LU (2006). Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett, 234, 168-75.
11. Cox TR, Erler JT (2011). Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech, 4, 165-78.
12. Dabrosin C, Chen J, Wang L, et al (2002). Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett, 185, 31-37.
13. Daley WP, Peters SB, Larsen M (2008). Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci, 121, 255-64.
14. Deryugina EI, Quigley JP (2012). Cell surface remodeling by plasmin: A new function for an old enzyme. J Biomed Biotechnol, 56, 4259-80.
15. Deryugina EI, Quigley JP (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev, 25, 9-34.
16. Didiasova M, Wujak L, Wygrecka M, et al (2014). From plasminogen to plasmin: role of plasminogen receptors in human cancer. Int J Mol Sci, 15, 21229-52.
17. Duffy MJ (2004). The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des, 10, 39-49.
18. Duffy MJ, McGowan PM, Harbeck N, et al (2014). uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res, 16, 428.
19. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2, 161-74.
20. Elangovan S, Hsieh TC, Wu JM (2008). Growth inhibition of human MDA-MB-231 breast cancer cells by?-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res, 28, 2641-47.
21. Flower G, Fritz H, Balneaves LG, et al (2014). Flax and breast cancer: A systematic review. Integr Cancer Ther, 13, 181-92.
22. Frankowski H, Gu YH, Heo JH (2012). Use of gel zymography to examine matrix metalloproteinase (Gelatinase) expression in brain tissue or in primary Glial cultures. Methods Mol Biol, 814, 221-33.
23. Fuentealba C, Figuerola F, Estévez AM, et al (2014). Bioaccessibility of lignans from flaxseed (Linum usitatissimum L. ) determined by single-batch in vitro simulation of the digestive process. J Sci Food Agric, 94, 1729-38.
24. Gebäck T, Schulz MMP, Koumoutsakos P (2009). TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques, 46, 265-74.
25. Green KA, Lund LR (2005). ECM degrading proteases and tissue remodelling in the mammary gland. Bioessays, 27, 894-03.
26. Hynes RO (2009). The extracellular matrix: not just pretty fibrils. Science, 326, 1216-9.
27. Jungeström MB, Thompson LU, Dabrosin C (2007). Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res, 13, 1061-67.
28. Justus CR, Leffler N, Ruiz-Echevarria M (2014). In vitro cell migration and invasion assays. J Vis Exp, 88, e51046.
29. Kass L, Erler JT, Dembo M (2007). Mammary epithelial cell: Influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol, 39, 1987-94.
30. Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67.
31. Kousidou OC, Roussidis AE, Theocharis AD (2004). Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential. Anticancer Res, 24, 4025-30.
32. Levental KR, Yu H, Kass L, et al (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell, 139, 891-06.
33. Lu P, Takai K, Weaver VM, Werb Z (2011). Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol, 3, 1-24.
34. Lu P, Weaver VM, Werb Z (2012). The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol, 196, 395-06.
35. Magee PJ, McGlynn H, Rowland IR (2004). Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett, 208, 35-41.
36. Mali AV, Wagh UV, Hegde MV (2012). In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines. Indian J Cancer, 49, 181-7.
37. Mellatyar H, Akbarzadeh A, Rahmati M, et al (2014). Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pacific J Cancer Prev, 15, 8693-98.
38. Murphy G (2008). The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer, 8, 929-41.
39. Nabeshima K, Inoue T, Shimao Y, et al (2002). Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int, 52, 255-64.
40. Ranson M (2003). Plasminogen binding and cancer: promises and pitfalls. Front Biosci, 8, 294-04.
41. Saarinen NM, Power K, Chen J, et al (2006). Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer, 119, 925-31.
42. Schmitt M, Harbeck N, Brünner N, et al (2011). Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn, 11, 617-34.
43. Schmittgen TD, Livak KJ (2008). Analyzing real-time PCR data by the comparative CT method. Nat Protoc, 3, 1101-08.
44. Shimizu M, Cohen B, Goldvasser P, et al (2011). Plasminogen activator uPA is a direct transcriptional target of the JAG1-notch receptor signaling pathway in breast cancer. Cancer Res, 71, 277-86.
45. Sternlicht MD, Werb Z (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 17, 463-16.
46. Strober W (2001). Trypan blue exclusion test of cell viability. Curr Protoc Immunol. A3-B. (vol)(pages?).
47. Syrovets T, Lunov O, Simmet T (2012). Plasmin as a proinflammatory cell activator. J Leukoc Biol, 92, 509-19.
48. Tang L, Han X (2013). The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother, 67, 179-82.
49. Vakonakis I, Campbell ID (2007). Extracellular matrix: from atomic resolution to ultrastructure. Curr Opin Cell Biol, 19, 578-83.
50. Wang L, Chen J, Thompson LU (2005). The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer, 116, 793-8.
51. Wang LQ (2002). Mammalian phytoestrogens: Enterodiol and enterolactone. J Chromatogr B, 777, 289-09.
52. Welshons WV, Murphy CS, Koch R, et al (1987). Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat, 10, 169-75.
53. Xiong XY, Hu XJ, Li Y, et al (2015). Inhibitory effects of enterolactone on growth and metastasis in human breast cancer. Nutr Cancer, 67, 1326-34.
54. Yan L, Yee JA, Li D, et al (1998). Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett, 124, 181-6.
55. Yu H, Mouw JK, Weaver VM (2011). Forcing form and function: Biomechanical regulation of tumor evolution. Trends Cell Biol, 21, 47-56.